No Data
No Data
Scinai Immunotherapeutics Battles Nasdaq Delisting
Scinai Immunotherapeutics Plans 1-for-10 Reverse Stock Split to Avoid Possible Delisting
Scinai Immunotherapeutics (SCNI) said Monday its board has approved a 1-for-10 reverse split of its American depository shares to take effect possibly on May 21 in a bid to lift its share price above
Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal
The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares (equivalent to a reverse split) Designed to Regain Compliance JERUSALEM, May 6, 2024 /PRNewswire/ -- Scinai Immunothera
Scinai Immunotherapeutics Advances NanoAb Pipeline
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersEliem Therapeutics (NASDAQ:ELYM) stock moved upwards by 51.6% to $4.05 during Thursday's pre-market session. The market value of their outstanding shares is at $112.2 million. Rallybio (NASDAQ:
12 Health Care Stocks Moving In Monday's After-Market Session
GainersKineta (NASDAQ:KA) shares increased by 24.3% to $0.67 during Monday's after-market session. The market value of their outstanding shares is at $7.3 million. Moleculin Biotech (NASDAQ:MBRX) stoc
No Data